Aureon Biosciences, Inc. — Form D/A
Aureon Biosciences, Inc. of YONKERS, NY, a company, filed a Form D amendment with the SEC on 2011-06-01. The offering totals $15.0M, of which $13.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-06-01
- Form: D/A
- Accession: 0001331514-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $15.0M
- Amount sold: $13.0M
- Remaining: $2.0M
- Investors: 17
- Date of first sale: 2010-10-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-149520
Issuer
- Name: Aureon Biosciences, Inc.
- CIK: 0001331514
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 28 WELLS AVE, YONKERS, NY, 10701
- Phone: 914-377-4000
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Jose Velasco, M.D. | Director | Yonkers, NY |
| Kevin Johnson | Director | San Diego, CA |
| William Burkoth | Director | Ann Arbor, MI |
| Jose Costa, M.D. | Director | New Haven, CT |
| Paul Veronese | Director | Yonkers, NY |
| Robert Shovlin | Director | Yonkers, NY |
| Robert Shovlin | Executive Officer | Yonkers, NY |
| Peter Barrett, Ph.D. | Director | Cambridge, MA |
| Carlos Cordon-Cardo, M.D., Ph.D. | Director | New York, NY |
| Philippe Chambon, M.D., Ph.D. | Director | New York, NY |
| Robert Van Nostrand | Executive Officer | Yonkers, NY |
| Vijay Aggarwal, Ph.D. | Director | Yonkers, NY |
Other filings by this issuer (6)
More